American Bio Medica Corporation Year End 2007 Conference Call

KINDERHOOK, N.Y.--(BUSINESS WIRE)--March 13, 2008--American Bio Medica Corporation (NASDAQ:ABMC), a global provider of immunoassay diagnostic test kits, will release Year End 2007 results at close of market on Monday, March 17, 2008 and will hold its conference call to discuss the Year End results on Tuesday, March 18, 2008, at 11 AM Eastern Time (10 AM Central Time).

This call is being webcast by Thomson/CCBN and can be accessed at ABMC's Web site at www.abmc.com/investor/. Investors and interested parties are invited to participate. The webcast will be in listen-only mode. Listeners are requested to be online at least fifteen minutes early to register, as well as to download and install any complimentary audio software that might be required. To ask questions, you are invited to participate by phone. Within the United States, dial 1-866-322-1159 and internationally, dial 416-640-3404.

The call will be available for replay on the company's website at www.abmc.com/investor/ for 30 days.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.

About ABMC:

American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), Rapid TEC(R), RDS(R) InCup(R), Rapid TOX(R), and Rapid TOX Cup(TM) products test for the presence or absence of drugs of abuse in urine, while OralStat(R) and Rapid STAT(TM) tests for the presence or absence of drugs of abuse in oral fluids. ABMC's Rapid Reader(R) is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.

CONTACT: ABMC
Melissa Waterhouse, 518-758-8158 x107
mdwaterhouse@abmc.com

SOURCE: American Bio Medica Corporation